CYRAMZA® (ramucirumab)

 
Billing Information Ordering Information
HCPCS Codes
Code Description
J9308 Injection, ramucirumab (billing unit = 5 mg)
NDC
Code Dosage form and strength
00002-7669-01 CYRAMZA (ramucirumab for injection) 100 mg/10 mL (10 mg per mL) solution, single-dose vial
00002-7678-01 CYRAMZA (ramucirumab for injection) 500 mg/50 mL (10 mg per mL) solution, single-dose vial
Diagnosis Codes
Colorectal cancer
ICD-10-CM Description
Malignant neoplasm of colon
C18.3 Hepatic flexure
C18.4 Transverse colon
C18.6 Descending colon
C18.7 Sigmoid colon
C18.0 Cecum
C18.1 Appendix
C18.2 Ascending colon
C18.5 Splenic flexure
Other specified sites of large intestine
C18.9 Colon, unspecified
C18.8 Overlapping sites of colon
Malignant neoplasm of rectum, rectosigmoid junction, and anus
C19 Rectosigmoid junction
C20 Rectum
Other sites of rectum, rectosigmoid junction, and anus
C21.8 Overlapping sites of rectum, anus, and anal canal
Gastric cancer
ICD-10-CM Description
Malignant neoplasm of stomach
C16.0 Cardia
C16.4 Pylorus
C16.3 Pyloric antrum
C16.1 Fundus of stomach
C16.2 Body of stomach
C16.5 Lesser curvature of stomach, unspecified
C16.6 Greater curvature of stomach, unspecified
C16.8 Overlapping sites of stomach
C16.9 Stomach, unspecified site
Non-small cell lung cancer
ICD-10-CM Description
C33 Malignant neoplasm of trachea
C34.00 - unspecified Malignant neoplasm of main bronchus
C34.01 - right
C34.02 - left
C34.10 - unspecified Malignant neoplasm of upper lobe, bronchus, or lung
C34.11 - right
C34.12 - left
C34.2 Malignant neoplasm of middle lobe, bronchus, or lung
C34.30 - unspecified Malignant neoplasm of lower lobe, bronchus, or lung
C34.31 - right
C34.32 - left
C34.80 - unspecified Malignant neoplasm of other parts of bronchus or lung (overlapping sites)
C34.81 - right
C34.82 - left
C34.90 - unspecified Malignant neoplasm of bronchus or lung, unspecified
C34.91 - right
C34.92 - left
Drug Administration CPT® Code
Code Description
96413 Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug

Lilly has contracted with a network of specialty distributors and one specialty pharmacy to provide customers access to CYRAMZA.

If purchasing CYRAMZA directly, you may use the five specialty distributors and one specialty pharmacy listed here. You also have the option of ordering from our authorized specialty pharmacy partner shown below. For more information on purchasing, dispensing, or returning Lilly products, visit LillyTrade.com. For inquiries about this matter, contact Lilly at 1-800-LillyRx (1-800-545-5979).

Specialty Distributor Network
AmerisourceBergen Specialty Group
Order Entry Codes: 100 mg/10 mL - 42792, 500 mg/50 mL - 42793
Oncology Supply ASD Healthcare
P: (800) 633-7555, F: (800) 248-8205
oncologysupply.com
P: (800) 746-6273, F: (800) 547-9413
asdhealthcare.com
Cardinal Health Specialty Pharmaceutical Distribution
Order Entry Codes: 100 mg/10 mL - 4982419, 500 mg/50 mL - 4982435
Oncology Clinics Hospitals
P: (855) 740-1871, F: (888) 345-4916
cardinalhealth.com
/specialtyonline
P: (866) 476-1340, F: (888) 345-4916
cardinalhealth.com
/specialtyonline
CuraScript Specialty Distribution
Order Entry Codes: 100 mg/10 mL - 265012, 500 mg/50 mL - 265020
P: (877) 599-7748, F: (800) 862-6208
curascriptsd.com
McKesson Specialty Care Distribution Corporation
Order Entry Codes: 100 mg/10 mL - 983-231, 500 mg/50 mL - 983-232
McKesson Specialty Health McKesson Plasma and Biologics
P: (800) 482-6700, F: (800) 289-9285
mscs.mckesson.com
P: (877) 625-2566, F: (888) 752-7626
connect.mckesson.com
Smith Medical Partners
Order Entry Codes: 100 mg/10 mL - 375-8307, 500 mg/50 mL - 375-8315
P: (800) 292-9653, F: (630) 227-9220, smpspecialty.com
Authorized Specialty Pharmacy
Biologics Inc.
P: (800) 850-4306, F: (800) 823-4506, biologicsinc.com

Prescribing Information including BOXED WARNINGS

This information is presented for informational purposes only and is not intended to provide reimbursement or legal advice. Laws, regulations, and policies concerning reimbursement are complex and are updated frequently. Individual coding decisions should be based upon diagnosis and treatment of individual patients. Eli Lilly and Company does not guarantee success in obtaining insurance payments. While we have made an effort to be current as of the issue date of this website, the information may not be as current or comprehensive when you view it. Providers should contact third-party payers for specific information on their coverage, coding, and payment policies. Please consult with your legal counsel or reimbursement specialist for any reimbursement or billing questions. For more information please call the Lilly PatientOne program at 1-866-472-8663.

† FDA standard NDC has been “zero-filled” to ensure creation of an 11-digit code that meets HIPAA standards. The zero-fill location is indicated in bold.